Issues related to drug patents and exclusivities, no specific bill
Patent eligibility reform, no specific bill
FTC related issues, no specific bill
Issues related to World Trade Organization IP waiver, no specific bill Biosimilars reimbursement issues, no specific bill 
H.R. 3, Prescription drug pricing issues
FDA issues, no specific bill 
Vial size issues
Supply Chain Issues, no specific bill S. 99 The Medicare Drug Price Negotiation Act
Vial size issues, no specific bill
H.R.1319- the American Rescue Plan Act of 2021
Changes to Six Protected Classes & Part D Payment Modernization model for CY22
Issues related to Drug Pricing
Issues related to clinical trial diversity
Issues related to osteoporosis, no specific bill 
Issues related to international reference pricing and Most Favored Nation (MFN) model Interim Final Rule
Issues related to the 340B program, no specific bill
Reimbursement for biologics/biosimilars
Issues related to Part D redesign
Medicare Part D access issues for plan year 2020 and 2021, no specific bill
Issues related to patient affordability issues, including copay cards, copay accumulators, National Benefit Payment Parameters
Medicare End Stage Renal Disease Prospective Payment System (ESRD PPS) Proposed Rule (bundled payment for calcimimetics)
Patent thickets/product hopping, no specific bill
Mergers/acquisitions, no specific bill Issues related to corporate and international tax, including regarding Public Law 115-97, Tax Cuts and Jobs Act
Issues related to Puerto Rico
H.R. 7527, Medical Manufacturing, Economic Development, and Sustainability Act of 2020
Proposed Rule, Guidance Related to the Foreign Tax Credit, Clarification of Foreign-Derived Intangible Income
H.R. 6930, Manufacturing API, Drugs, and Excipients (MADE) in America Act of 2020
Issues related to OECD negotiations on the taxation of global income
CPT - Copyright/Patent/Trademark HCR - Health Issues MMM - Medicare/Medicaid TAX - Taxation/Internal Revenue Code
136 - Centers For Medicare and Medicaid Services (CMS) 11 - Executive Office of the President (EOP) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 11 - Executive Office of the President (EOP) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 11 - Executive Office of the President (EOP) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 11 - Executive Office of the President (EOP) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
AMGEN, INC.
601 13th Street, NW, 11th Floor North, WASHINGTON, DC, 20005, US
JORDAN LYNN LAYSON HELEN RHEE GREGORY PORTNER L NICOLE CURRIE WILLIAM O'BRIEN REBECCA MANDELL VICTORIA BLATTER HOWARD MOON JESSE KERNS JORDAN LYNN LAYSON WILLIAM O'BRIEN HELEN RHEE REBECCA MANDELL JESSE KERNS L NICOLE CURRIE GREGORY PORTNER VICTORIA BLATTER HOWARD MOON RUTH HOFFMAN JORDAN LYNN LAYSON L NICOLE CURRIE GREGORY PORTNER HELEN RHEE REBECCA MANDELL JESSE KERNS VICTORIA BLATTER WILLIAM O'BRIEN HOWARD MOON RUTH HOFFMAN L NICOLE CURRIE